Search Icon
Search Icon
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Life & the Law

Are pro-life state laws killing women?

Cardiovascular surgeon Dr. Gary Ott says his pregnant patients’ medical needs rarely call for delivering a baby early. Even more rarely does he have to decide whether a woman must deliver her baby before the child can survive outside the womb. Most health problems that women experience during pregnancy can be treated while preserving the lives of both mother and unborn baby—or, in the worst cases, delivering the child early instead of actively killing him or her.

Continue Reading at WORLD >>

Latest Posts

November 9, 2026 Minimalist illustration of a small, flat-roofed building serving as a United States abortion center, featuring two windows and a central door. Fact Sheet: Gestational Breakdown of Brick-and-Mortar Abortion Centers in The United States October 6, 2026 A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification. A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Ultrasound image showing the side profile of a human baby Inside The Government Decision That Opened Up Abortion Pill Floodgates

You Might Also Be Interested In

Minimalist illustration of a small, flat-roofed building serving as a United States abortion center, featuring two windows and a central door.

Fact Sheet: Gestational Breakdown of Brick-and-Mortar Abortion Centers in The United States

charlotte-lozier-institute Charlotte Lozier Institute
November 9, 2026
A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification.

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined.

Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image